0001689813-19-000066.txt : 20190919 0001689813-19-000066.hdr.sgml : 20190919 20190919210500 ACCESSION NUMBER: 0001689813-19-000066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190917 FILED AS OF DATE: 20190919 DATE AS OF CHANGE: 20190919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stock Elyse CENTRAL INDEX KEY: 0001785732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 191102573 BUSINESS ADDRESS: BUSINESS PHONE: (203) 404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 wf-form4_156894148158568.xml FORM 4 X0306 4 2019-09-17 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001785732 Stock Elyse C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET NEW HAVEN CT 06510 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 47.32 2019-09-17 4 A 0 11000 0 A 2029-09-16 Common Shares 11000.0 11000 I By Spouse The option became exercisable with respect to 2,750 of the shares underlying the option on the grant date (September 17, 2019), and the remaining 8,250 shares underlying the option vest in three equal installments on September 17, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer as of each applicable vesting date. This stock option is held by the reporting person's spouse, who is a consultant for the issuer. /s/ Jim Engelhart, Attorney-in-fact 2019-09-19